Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17.
BACKGROUND:Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who rece...
Main Authors: | Justin C Yang, Andres Roman-Urrestarazu, Carol Brayne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0226349 |
Similar Items
-
Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
by: Justin C Yang, et al.
Published: (2020-01-01) -
Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
by: Marchand Kirsten, et al.
Published: (2012-01-01) -
Substitution treatment for opioid addicts in Germany
by: Gerlach Ralf, et al.
Published: (2007-02-01) -
Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
by: Florence Noble, et al.
Published: (2019-01-01) -
Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
by: Bastian Rosner, et al.
Published: (2019-01-01)